IP Library › Granted Patent US 12,402,628
Granted Patent B2
US 12,402,628 · App. 18/589,336 · Granted Sep 2, 2025

Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating

Inventors: Hojabr Alimi (Petaluma, CA); Sridhar Govinda Prasad (San Diego, CA); Surya Kanta De (San Diego, CA)
Assignee: Collidion, Inc.
A01N59/08A01N33/12A01N59/00A01N59/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,402,628
App. No.
18/589,336
Granted
Sep 2, 2025
Kind
B2
Abstract

The present specification discloses a composition comprising, consisting essentially of, or consisting of hypochlorous acid or free available chlorine in combination with one or more quaternary compounds or silicon quaternary compounds, one or more guanide-containing compounds, one or more alcohols, one or more metallic particles, one or more metal salts, or any combination thereof. The present specification further discloses a kit comprising, consisting essentially of, or consisting of a one or more containers including a composition disclosed herein or components which make up such compositions as well as methods and uses for such compositions and kits.

Claims (29)

1. A composition comprising:

(i) about 350 ppm to about 450 ppm of hypochlorous acid or about 350 ppm to about 450 ppm of free available chlorine;

(ii) at least 50 ppm to at most 100 ppm of a copper (II) chloride salt;

(iii) at least 50 ppm to at most 100 ppm of an iron (III) chloride salt; and

(iv) at least 50 ppm to at most 100 ppm of a zinc chloride salt.

2. The composition according to claim 1 , wherein the hypochlorous acid or the free available chlorine is present in an amount of at most 425 ppm.

3. The composition according to claim 2 , wherein the hypochlorous acid or the free available chlorine is present in an amount of at most 400 ppm.

4. The composition according to claim 1 , wherein the hypochlorous acid or the free available chlorine is present in an amount of about 375 to about 400 ppm.

5. The composition according to claim 1 , wherein each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of at least 70 ppm.

6. The composition according to claim 5 , wherein each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of at most 90 ppm.

7. The composition according to claim 1 , wherein each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of 60 ppm, 65 ppm, 70 ppm, 75 ppm, 80 ppm, 85 ppm, 90 ppm, 95 ppm or 100 ppm.

8. The composition according to claim 7 , wherein each of the copper (II) chloride salt, the iron (I III) chloride salt and the zinc chloride salt is present in an amount of 75 ppm, 80 ppm or 85 ppm.

9. The composition according to claim 8 , wherein each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of 80 ppm.

10. The composition according to claim 1 , wherein the the composition further comprises an aqueous carrier.

11. The composition according to claim 1 , wherein the composition has a pH of about 2 to about 6, or has a pH of about 3 to about 5.

12. The composition of claim 1 , wherein the composition does not contain a surfactant.

13. A composition consisting essentially of:

(i) about 350 ppm to about 450 ppm of hypochlorous acid or about 350 ppm to about 450 ppm free available chlorine;

(ii) at least 50 ppm to at most 100 ppm of a copper (II) chloride salt;

(iii) at least 50 ppm to at most 100 ppm of an iron (III) chloride salt; and

(iv) at least 50 ppm to at most 100 ppm of a zinc chloride salt; and

(v) one or more carriers.

14. The composition according to claim 13 , wherein the hypochlorous acid or the free available chlorine is present in an amount of at most 425 ppm.

15. The composition according to claim 13 , wherein each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of at least 70 ppm to at most 90 ppm.

16. The composition of claim 13 , wherein the hypochlorous acid or the free available chlorine is present in an amount of about 375 to about 400 ppm; and each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of at least 70 ppm to at most 90 ppm.

17. The composition of claim 16 , wherein each of the copper (II) chloride salt, the iron (III) chloride salt and the zinc chloride salt is present in an amount of 80 ppm.

18. The composition of claim 16 , wherein the composition has a pH of about 3 to about 5.

19. The composition of claim 13 , wherein the composition has a pH of about 2 to about 6 or has a pH of about 3 to about 5.

20. The composition of claim 13 , wherein the composition does not contain a surfactant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 29, 2024
From: ALIMI, HOJABR; PRASAD, SRIDHAR GOVINDA; DE, SURYA KANTA
To: COLLIDION, INC.
Reel/Frame 066599/0089 →
Continuity (5)
Continuation 17654786 · Mar 14, 2022
Continuation 16247501 · Jan 14, 2019
Provisional Application 62721991 · Aug 23, 2018
Provisional Application 62617263 · Jan 14, 2018
Related Publication 20240196900A1 · Jun 20, 2024
References Cited (264)
US 2140401A · Fink · 1938 [cited by applicant]
US 2810401A · Stansbury · 1957 [cited by applicant]
US 3914397A · Mueller · 1975 [cited by applicant]
US 4105406A · Murray · 1978 [cited by applicant]
US 4190638A · Hoekje et al. · 1980 [cited by applicant]
US 4394517A · Martin et al. · 1983 [cited by applicant]
US 4561994A · Rubin et al. · 1985 [cited by applicant]
US 4670592A · Eakin et al. · 1987 [cited by applicant]
US 4814334A · Salkin · 1989 [cited by applicant]
US 4908215A · Perlman · 1990 [cited by applicant]
US 5019173A · Gettings et al. · 1991 [cited by applicant]
US 5098970A · O'Lenick et al. · 1992 [cited by applicant]
US 5284833A · McAnalley et al. · 1994 [cited by applicant]
US 5322677A · Shaffer et al. · 1994 [cited by applicant]
US 5332511A · Gay et al. · 1994 [cited by applicant]
US 5364464A · Sereboff · 1994 [cited by applicant]
US 5368749A · La Zonby · 1994 [cited by applicant]
US 5547662A · Khan et al. · 1996 [cited by applicant]
US 5700742A · Payne · 1997 [cited by applicant]
US 5750579A · Kamishita et al. · 1998 [cited by applicant]
US 5885562A · Lowry et al. · 1999 [cited by applicant]
US 5902227A · Rivas · 1999 [cited by applicant]
US 5914040A · Pescher et al. · 1999 [cited by applicant]
US 5987824A · Fuller · 1999 [cited by applicant]
US 6029709A · Burgess · 2000 [cited by applicant]
US 6127591A · Shah · 2000 [cited by applicant]
US 6180684B1 · Sawan et al. · 2001 [cited by applicant]
US 6207201B1 · Piacenza · 2001 [cited by applicant]
US 6245361B1 · Merritt · 2001 [cited by applicant]
US 6333054B1 · Rogozinski · 2001 [cited by applicant]
US 6426066B1 · Najafi et al. · 2002 [cited by applicant]
US 6455086B1 · Trinh et al. · 2002 [cited by applicant]
US 6517730B1 · Rex · 2003 [cited by applicant]
US 6544401B1 · Colic · 2003 [cited by applicant]
US 6815408B2 · Wegner · 2004 [cited by applicant]
US 6866870B2 · Day · 2005 [cited by applicant]
US 7008545B2 · Cronan et al. · 2006 [cited by applicant]
US 7048859B1 · Moffett · 2006 [cited by applicant]
US 7192554B2 · Read · 2007 [cited by applicant]
US 7323118B2 · Calderon · 2008 [cited by applicant]
US 7344725B2 · Ketelson et al. · 2008 [cited by applicant]
US 7351684B2 · Tichy et al. · 2008 [cited by applicant]
US 7429556B2 · Delcomyn et al. · 2008 [cited by applicant]
US 7700076B2 · Tamarkin et al. · 2010 [cited by applicant]
US 7700530B2 · Mundschau et al. · 2010 [cited by applicant]
US 7718122B2 · Smith et al. · 2010 [cited by applicant]
US 7884089B2 · Gimvang · 2011 [cited by applicant]
US 7897403B2 · Read · 2011 [cited by applicant]
US 8062500B2 · Sumita · 2011 [cited by applicant]
US 8147444B2 · Alimi · 2012 [cited by applicant]
US 8277827B2 · Toreki et al. · 2012 [cited by applicant]
US 8318654B2 · Hoffman et al. · 2012 [cited by applicant]
US 8460701B2 · Karagoezian · 2013 [cited by applicant]
US 8642527B2 · Van Buskirk et al. · 2014 [cited by applicant]
US 8784901B2 · Karagoezian · 2014 [cited by applicant]
US 8834445B2 · Alimi · 2014 [cited by applicant]
US 8840873B2 · Alimi · 2014 [cited by applicant]
US 8840911B2 · Flugge-Berendes et al. · 2014 [cited by applicant]
US 8883222B2 · Norton · 2014 [cited by applicant]
US 8945630B2 · Calderon · 2015 [cited by applicant]
US 9072717B2 · Karagoezian · 2015 [cited by applicant]
US 9072726B2 · Alimi et al. · 2015 [cited by applicant]
US 9168318B2 · Alimi · 2015 [cited by applicant]
US 9226495B2 · Berentsveig et al. · 2016 [cited by applicant]
US 9273220B2 · Scheuing · 2016 [cited by applicant]
US 9326995B2 · Stucky et al. · 2016 [cited by applicant]
US 9381214B2 · Sampson et al. · 2016 [cited by applicant]
US 9474768B1 · Richards et al. · 2016 [cited by applicant]
US 9486479B2 · Northey · 2016 [cited by applicant]
US 9498548B2 · Alimi · 2016 [cited by applicant]
US 9597353B2 · Hoover · 2017 [cited by applicant]
US 9622480B2 · Karagoezian · 2017 [cited by applicant]
US 9642876B2 · Alimi · 2017 [cited by applicant]
US 9782434B2 · Alimi · 2017 [cited by applicant]
US 9833471B1 · Richards et al. · 2017 [cited by applicant]
US 10010081B2 · Karagoezian · 2018 [cited by applicant]
US 10412968B2 · Alimi et al. · 2019 [cited by applicant]
US 10626559B2 · Kolari et al. · 2020 [cited by applicant]
US 11272710B2 · Alimi · 2022 [cited by examiner]
US 11365524B1 · Reardon et al. · 2022 [cited by applicant]
US 11910797B2 · Alimi · 2024 [cited by examiner]
US 20010016589A1 · Modak et al. · 2001 [cited by applicant]
US 20020022660A1 · Jampani et al. · 2002 [cited by applicant]
US 20030109411A1 · Kilkenny et al. · 2003 [cited by applicant]
US 20030138498A1 · Yoshikawa et al. · 2003 [cited by applicant]
US 20030150357A1 · Cohen · 2003 [cited by applicant]
US 20030209490A1 · Camp et al. · 2003 [cited by applicant]
US 20040003473A1 · Glenn et al. · 2004 [cited by applicant]
US 20040050781A1 · Coffey et al. · 2004 [cited by applicant]
US 20040126514A1 · McGee et al. · 2004 [cited by applicant]
US 20040127614A1 · Jiang et al. · 2004 [cited by applicant]
US 20040214785A1 · Dees et al. · 2004 [cited by applicant]
US 20040219227A1 · Modak et al. · 2004 [cited by applicant]
US 20050139808A1 · Alimi · 2005 [cited by applicant]
US 20050142157A1 · Alimi · 2005 [cited by applicant]
US 20050239675A1 · Makansi · 2005 [cited by applicant]
US 20060003023A1 · Williams · 2006 [cited by applicant]
US 20060073212A1 · Palmer · 2006 [cited by applicant]
US 20060140998A1 · Nakanishi et al. · 2006 [cited by applicant]
US 20060193789A1 · Tamarkin et al. · 2006 [cited by applicant]
US 20060231505A1 · Mayer et al. · 2006 [cited by applicant]
US 20060281663A1 · Asmus · 2006 [cited by applicant]
US 20070217946A1 · Smith et al. · 2007 [cited by applicant]
US 20070231247A1 · Bromberg et al. · 2007 [cited by applicant]
US 20080014289A1 · Li · 2008 [cited by applicant]
US 20080031973A1 · Lee · 2008 [cited by applicant]
US 20090117164A1 · Toreki et al. · 2009 [cited by applicant]
US 20090148342A1 · Bromberg et al. · 2009 [cited by applicant]
US 20090246165A1 · Toreki et al. · 2009 [cited by applicant]
US 20090258083A1 · Calderon · 2009 [cited by examiner]
US 20100028290A1 · Sokol · 2010 [cited by applicant]
US 20100055196A1 · MacGregor · 2010 [cited by applicant]
US 20100210745A1 · McDaniel et al. · 2010 [cited by applicant]
US 20100284951A1 · Pongprapansiri et al. · 2010 [cited by applicant]
US 20110052506A1 · Abel et al. · 2011 [cited by applicant]
US 20110135702A1 · Hoffman et al. · 2011 [cited by applicant]
US 20110236504A1 · Hata · 2011 [cited by examiner]
US 20120036787A1 · Rodrigue et al. · 2012 [cited by applicant]
US 20120082791A1 · Liversage · 2012 [cited by applicant]
US 20120121679A1 · Cannon et al. · 2012 [cited by applicant]
US 20120164235A1 · Northey · 2012 [cited by applicant]
US 20120164236A1 · Iwasa · 2012 [cited by examiner]
US 20120223022A1 · Hassler et al. · 2012 [cited by applicant]
US 20120258059A1 · Iwama et al. · 2012 [cited by applicant]
US 20120269904A1 · Northey · 2012 [cited by applicant]
US 20120301528A1 · Uhlmann et al. · 2012 [cited by applicant]
US 20130129648A1 · Nguyen et al. · 2013 [cited by applicant]
US 20130171224A1 · Percival et al. · 2013 [cited by applicant]
US 20130259955A1 · Chen et al. · 2013 [cited by applicant]
US 20140115750A1 · Kassam et al. · 2014 [cited by applicant]
US 20140115765A1 · Carpenter et al. · 2014 [cited by applicant]
US 20140134224A1 · Mallet et al. · 2014 [cited by applicant]
US 20150119245A1 · Robertson et al. · 2015 [cited by applicant]
US 20150125543A1 · Croke et al. · 2015 [cited by applicant]
US 20150190536A1 · Degala et al. · 2015 [cited by applicant]
US 20150231173A1 · Sampson et al. · 2015 [cited by applicant]
US 20150264935A1 · Chang · 2015 [cited by applicant]
US 20150265666A1 · Modak et al. · 2015 [cited by applicant]
US 20150290102A1 · Cozean et al. · 2015 [cited by applicant]
US 20150297411A1 · Wang et al. · 2015 [cited by applicant]
US 20150306137A1 · Alimi · 2015 [cited by applicant]
US 20150335544A1 · Lull et al. · 2015 [cited by applicant]
US 20150351389A1 · Kolari et al. · 2015 [cited by applicant]
US 20160024667A1 · Shanahan et al. · 2016 [cited by applicant]
US 20160120183A1 · Northey · 2016 [cited by applicant]
US 20160143944A1 · Panicheva et al. · 2016 [cited by applicant]
US 20160166495A1 · Sarkar et al. · 2016 [cited by applicant]
US 20160166497A1 · Saxena et al. · 2016 [cited by applicant]
US 20160256369A1 · Dutton et al. · 2016 [cited by applicant]
US 20160289480A1 · Maddalone · 2016 [cited by applicant]
US 20160330969A1 · O'Connell · 2016 [cited by applicant]
US 20160338917A1 · Daniel · 2016 [cited by applicant]
US 20170042800A1 · Wenzel et al. · 2017 [cited by applicant]
US 20170071980A1 · Alimi · 2017 [cited by applicant]
US 20170156336A1 · Joshi · 2017 [cited by applicant]
US 20170202877A1 · Hoover et al. · 2017 [cited by applicant]
US 20170290789A1 · Dicosmo · 2017 [cited by applicant]
US 20170304874A1 · Hennigan · 2017 [cited by applicant]
US 20180235852A1 · Rodriguez · 2018 [cited by applicant]
US 20190000086A1 · Alimi et al. · 2019 [cited by applicant]
US 20190216090A1 · Alimi et al. · 2019 [cited by applicant]
CN 101310726A · 2008 [cited by applicant]
CN 101802159A · 2010 [cited by applicant]
CN 102265893A · 2011 [cited by applicant]
CN 104324047A · 2015 [cited by applicant]
EP 0099209A1 · 1984 [cited by applicant]
EP 0129980B1 · 1989 [cited by applicant]
EP 1119347B1 · 2005 [cited by applicant]
EP 1465671B1 · 2005 [cited by applicant]
EP 1355681B1 · 2006 [cited by applicant]
EP 1418881B1 · 2008 [cited by applicant]
EP 1874913B1 · 2008 [cited by applicant]
EP 1941797B1 · 2010 [cited by applicant]
EP 3028568A1 · 2016 [cited by applicant]
EP 3205358A1 · 2017 [cited by applicant]
EP 3223611B1 · 2020 [cited by applicant]
GB 2541407A · 2017 [cited by applicant]
JP 57061099A · 1982 [cited by applicant]
JP S6253902A · 1987 [cited by applicant]
JP 5068408B2 · 2012 [cited by applicant]
WO 1997031533A1 · 1997 [cited by applicant]
WO 2000015036A1 · 2000 [cited by applicant]
WO 2001041567A1 · 2001 [cited by applicant]
WO 2006000756A1 · 2006 [cited by applicant]
WO 2007100776A2 · 2007 [cited by applicant]
WO 2009005936A1 · 2009 [cited by applicant]
WO 2009010749A2 · 2009 [cited by applicant]
WO 2009058274A1 · 2009 [cited by applicant]
WO 2009125297A2 · 2009 [cited by applicant]
WO 2009133616A1 · 2009 [cited by applicant]
WO 2010011856A2 · 2010 [cited by applicant]
WO 2010148004A1 · 2010 [cited by applicant]
WO 2013051013A2 · 2013 [cited by applicant]
WO 2013061082A1 · 2013 [cited by applicant]
WO 2013090873A2 · 2013 [cited by applicant]
WO 2013109850A2 · 2013 [cited by applicant]
WO 2014147643A2 · 2014 [cited by applicant]
WO 2015002932A1 · 2015 [cited by applicant]
WO 2015145100A1 · 2015 [cited by applicant]
WO 2016040738A1 · 2016 [cited by applicant]
WO 2016100543A2 · 2016 [cited by applicant]
WO 2019006217A1 · 2019 [cited by applicant]
WO 2022046955A1 · 2022 [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2018/040155, pp. 9 (Aug. 21, 2018). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2018/054263, pp. 7 (Feb. 4, 2019). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2018/057403, (Jan. 11, 2019). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2019/013542, pp. 5 (May 8, 2019). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2020/037665, pp. 6 (Sep. 9, 2020). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2020/037666, pp. 6 (Sep. 14, 2020). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2021/047627, pp. 8 (Feb. 8, 2022). [cited by applicant]
WIPO, PCT Form ISA237, Written Opinion for International Patent Application Serial No. PCT/US2023/079291, pp. 8 (Apr. 26, 2024). [cited by applicant]
Wolanov, et al, Zinc Dioxide Nanoparticulates: A Hydrogen Peroxide Source at Moderate pH, Environmental Science and Technology (2013). [cited by applicant]
You, et al, The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity, Mol Biol Rep (2012). [cited by applicant]
Yuan, et al., Reaction of Silver Nanoparticles in the Disinfection Process, Chemosphere 93: 619-625 (2013). [cited by applicant]
Anonymous, Auxopan Product Label, Briotech (2016). [cited by applicant]
Anonymous, Disinfectant Manual, Features, Usage, and the Cautions on Disinfectants, pp. 15 to 198 Feb. 1, 2012). [cited by applicant]
Anonymous, Hypochlorous Acid Handling, USDA Technical Evaluation Report (Aug. 13, 2015). [cited by applicant]
Anonymous, Preventing Cross-Contamination in Endoscope Processing: FDA Safety Communication (Nov. 19, 2009). [cited by applicant]
CNIPA, First Office Action for Chinese Patent Application Serial No. 201880054035X (Aug. 11, 2021). [cited by applicant]
CNIPA, Second Office Action for Chinese Patent Application Serial No. 201880054035X (Mar. 23, 2022). [cited by applicant]
Dequeiroz, et al, Antimicrobial activity and effectiveness of a combination of sodium hypochlorite and hydrogen perozide in killing and removing Pseudomonas aeruginosa biofilms from surfaces, Journal of Applied Microbio… [cited by applicant]
Dimapilis, et al, Zinc oxide nanoparticles for water disinfection, Sustainable Environment Research (2018). [cited by applicant]
Echa-Europa, Polyhexamethylene Biguanide, EU Reg. No. 528/2012, pp. 132 (Jun. 2015). [cited by applicant]
Eissa, et al., Assessment of Antimicrobial Activity of Novel Disinfectant Based on Peroxygen/Biguanide/Alcohol Combination, Indonesian J. Pharm. 25(3): 153-163 (2014). [cited by applicant]
Eryilmaz, et al., Hypochlorous Acid - Analytical Methods and Antimicrobial Activity, Trop. J. Pharma. Res. 12(1): 123-126 (2013). [cited by applicant]
Google Patents English Translation of JPS6253902A (1987). [cited by applicant]
Gordon, et al., Synthesis and characterization of zinc/iron oxide composite nanoparticles and their antibacterial properties, Colloids and Surfaces A: Physiochemical Engineering Aspects (2011). [cited by applicant]
Hughson, et al., Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid, PLoS Pathog 12(9): e1005914 (2016). [cited by applicant]
IMPI, Office Action for Mexican Patent Application Serial No. MX/a/2019/015822 (Mar. 23, 2022). [cited by applicant]
IPO, Office Action for Israeli Patent Application Serial No. 271623 (Oct. 19, 2021). [cited by applicant]
IPOS, Invitation to Respond to Written Opinion for Singapore Patent Application Serial No. 11201912534S (Apr. 27, 2021). [cited by applicant]
IPOS, Invitation to Respond to Written Opinion for Singapore Patent Application Serial No. 11201912534S (Oct. 20, 2021). [cited by applicant]
IPOS, Notice of Eligibility for Grant, SG Application No. 11201912534S (May 17, 2022). [cited by applicant]
Kuruvilla, et al., Antimicrobial Activity of 2.5% Sofium Hypochlorite and 0.2% Ch; orhexidine Gluconate Seperately and Combined, as Endodontic Irrigants, J. Endodon. 24(7): 472-476 (1998). [cited by applicant]
Leung, et al., Topical Hypochlorite Ameliorates NF-κl B-Mediated Skin Diseases in Mice, J. Clin. Invest. 123(12): 5361-5370 (2013). [cited by applicant]
Li, et al., Synthesis and Characterization of Biocompatible Antimicrobial N-Halamine-Functionalized Titanium Dioxide Core-Shell Nanoparticles, Colloids Surf. B: Biointerfaces 148: 511-517 (2016). [cited by applicant]
Martin, et al., Antibacterial Properties and Mechanism of Activity of a Novel Silver-Stabilized Hydrogen Peroxide, PLOS (2015). [cited by applicant]
Mitchell, et al., Evaluation of a Combination of Sodium Hypochlorite and Polyhexamethylene Biguanide as an Egg Wash for Red-Eared Slider Turtles (Trachemys scripta elegans) to Suppress or Eliminate Salmonella Organisms … [cited by applicant]
Mohammed, et al, Novel approach for controlling resistant Listeria monocylogenes to anlimicrobials using different disinfectants types loaded on silver nanoparticles (AgNPs), Environmental Science and Pollution Research… [cited by applicant]
Noguchi, et al., Efficacy of Surgical Antiseptic Handrub Containing Phmb, Bmc Proceedings 5(Suppl 6): P270 (2011). [cited by applicant]
Phull, et al, “The development and evaluation of ultrasound in the biocidal treatment of water” pp. 157-164, Ultrasonics Sonochermistry, vol. 4, (1997). [cited by applicant]
Polo, et al, Halide removal from waters by silver nanoparticles and hydrogent peroxide, Science of the Total Environment (2017). [cited by applicant]
Rutala, et al, Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008, CDC, p. 158 (2008). [cited by applicant]
Sanchez-Sanhueza, et al, Copper Nanoparticles as Potential Antimicrobial Agent in Disinfecting Root Canals, A Systematic Review, Int. J. Odonlostomal (2016). [cited by applicant]
Saraya Europe, Alsoft E, pp. 2 (2021). [cited by applicant]
Shiguki, Detergent Sanitizers as Tools of Harmful Microbe Measures in Food Factories and Their Developments, J. Brewery Assoc. 108(3): 141-155 (2013). [cited by applicant]
USPTO, Final Office Action for U.S. Appl. No. 16/994,847 (Feb. 16, 2022). [cited by applicant]
USPTO, Non-Final Office Action for U.S. Appl. No. 16/994,862 (Jul. 21, 2021). [cited by applicant]
USPTO, Non-Final Office Action for U.S. Appl. No. 16/994,847 (Jul. 8, 2021). [cited by applicant]
Vervier, et al., A Multifunctional Ingredient for Next-Generation Skin Care Products, Dow Corning Europe Form No. 27-1237B-01 (Unknown Date). [cited by applicant]
Walia, et al., The Efficacy of Different Cleaning and Disinfection Procedures to Reduce Salmonella and Enterobacteriaceae in the Lairage Environment of a Pig Abattoir, Int. J. Food Microbiol. 246: 64-71 (2017). [cited by applicant]
WIPO, PCT Form IB373, International Preliminary Report on Patentability for International Patent Application Serial No. PCT/US2018/040155, pp. 11 (Jan. 9, 2020). [cited by applicant]
WIPO, PCT Form IB373, International Preliminary Report on Patentability for International Patent Application Serial No. PCT/US2018/054263, pp. 9 (Apr. 16, 2020). [cited by applicant]
WIPO, PCT Form IB373, International Preliminary Report on Patentability for International Patent Application Serial No. PCT/US2018/057403 (May 7, 2020). [cited by applicant]
WIPO, PCT Form IB373, International Preliminary Report on Patentability for International Patent Application Serial No. PCT/US2019/013542, pp. 7 (Jul. 14, 2020). [cited by applicant]
WIPO, PCT Form IB373, International Preliminary Report on Patentability for International Patent Application Serial No. PCT/US2020/037665, pp. 8 (Dec. 23, 2021). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2018/040155, pp. 4 Aug. 21, 2018). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2018/054263, p. 4 (Feb. 4, 2019). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2018/057403, (Jan. 11, 2019). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2019/013542, pp. 4 (May 8, 2019). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2020/037665, pp. 4 (Sep. 9, 2020). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2020/037666, pp. 4 (Sep. 14, 2020). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2021/047627, pp. 4 (Feb. 8, 2022). [cited by applicant]
WIPO, PCT Form ISA210, International Search Report for International Patent Application Serial No. PCT/US2023/079291, pp. 4 (Apr. 26, 2024). [cited by applicant]